Greg Bell answers the questions “What are some of the more significant structural changes that will shape our industry in the future?” and “Are pharmaceutical companies going to continue to be rewarded for innovation?” in a Future Pharmaceuticals article.
From climate risk to resilience: what insurers must do next
In this article by Marakon’s Ofir Eyal, he discusses the crucial role insurers can take by financing and insuring green technologies and supporting the energy...